Abaniel, Rogelio R.
HRN: 27-45-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2025
CEFTRIAXONE 1G (VIAL)
07/08/2025
07/14/2025
IV
2g
OD
Cap-mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes